============================================================
QUALITATIVE ERROR ANALYSIS REPORT
Generated on: 2025-08-21 14:01:09
Model: Phi-3.5 2.7B
Dataset: NDFRT
============================================================

1. BASIC PERFORMANCE METRICS:
   Accuracy: 0.958
   Precision: 0.922
   Sensitivity: 1.000
   F1-Score: 0.960
   Total samples: 238
   TP: 119, TN: 109, FP: 10, FN: 0

2. SMILES COMPLEXITY ANALYSIS:
   False Positives: 10 cases
     Avg combined SMILES length: 189.7 ± 129.7
   True Positives: 119 cases
     Avg combined SMILES length: 127.7 ± 65.5
   True Negatives: 109 cases
     Avg combined SMILES length: 113.1 ± 47.3

3. GENE TARGET COMPLEXITY ANALYSIS:
   False Positives: 10 cases
     Avg combined gene targets: 14.8 ± 17.7
   True Positives: 119 cases
     Avg combined gene targets: 9.8 ± 11.2
   True Negatives: 109 cases
     Avg combined gene targets: 4.4 ± 5.6

4. ORGANISM PATTERN ANALYSIS:
   Top false positives organism pairs:
     Humans - Humans: 7 cases
     Escherichia coli (strain K12) - Humans: 1 cases
     Staphylococcus aureus - Escherichia coli (strain K12): 1 cases
     Baker's yeast - Humans: 1 cases

5. MOST PROBLEMATIC DRUGS:
   Nintedanib: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Bisphenol Z: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Olmesartan: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Cefpiramide: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Platensimycin: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Thiopental: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   (R)-minalrestat: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Hydroxocobalamin: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)
   Pyridoxal phosphate: 1.000 error rate
     (1/1 errors: 1 FP, 0 FN)

6. SPECIFIC ERROR EXAMPLES:
   False Positives (predicted interaction, but no real interaction):
     1. Nintedanib + Bisphenol Z
        Organisms: Humans - Humans
        Gene targets: 12 - 1
     2. S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE + Olmesartan
        Organisms: Escherichia coli (strain K12) - Humans
        Gene targets: 1 - 1
     3. Cefpiramide + Platensimycin
        Organisms: Staphylococcus aureus - Escherichia coli (strain K12)
        Gene targets: 7 - 1
     4. Thiopental + (R)-minalrestat
        Organisms: Humans - Humans
        Gene targets: 12 - 1
     5. Hydroxocobalamin + Pyridoxal phosphate
        Organisms: Humans - Humans
        Gene targets: 7 - 53

7. SUMMARY INSIGHTS:
   - Model tends to over-predict interactions (more false positives than false negatives)
   - High sensitivity but lower precision - good at catching interactions but with some false alarms

Report generation completed successfully.
============================================================
